Literature DB >> 12086073

Persistence of anti-leptospiral IgM, IgG and agglutinating antibodies in patients presenting with acute febrile illness in Barbados 1979-1989.

P Cumberland1, C O Everard, J G Wheeler, P N Levett.   

Abstract

The persistence of anti-leptospiral IgM and IgG antibodies and agglutinating antibodies was studied in serologically confirmed cases of severe leptospirosis during the acute illness and over periods of several years after recovery. The antibody response in non-leptospirosis patients presenting to hospital with similar symptoms over the same period of time was used to estimate the background antibody level to leptospirosis in the community. All patients enrolled in the study had blood samples collected twice in the acute stage of illness, once during convalescence and then annually from the time of initial hospitalisation until the end of the study period. Six hundred and thirty-eight patients presented to hospital with acute febrile illness, of whom 321 were diagnosed with leptospirosis. Patients who had severe leptospirosis commonly remained seropositive, with IgM, IgG and agglutinating antibodies detectable for several years after infection. A significant proportion of cases had high titres of agglutinating antibody detectable by the microscopic agglutination test (> or = 800). There were marked differences in the magnitude and duration of persistence of agglutinating antibodies directed against different serogroups. More than 20% of cases with evidence of infection with serogroup Autumnalis retained titres of >800, 4 years after the acute illness. In one case a titre of 800 was detected 11 years after infection. Persistence of agglutinating antibody titres can create problems in interpretation of serological results and make it impossible to estimate the time of infection, given a specific titre. This study demonstrates that in endemic areas where seroprevalence is high, use of a single elevated titre is not reliable to define a current infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 12086073     DOI: 10.1023/a:1015509105668

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  27 in total

1.  Leptospirosis worldwide, 1999.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1999-07-23

2.  Detection of dengue infection in patients investigated for leptospirosis in Barbados.

Authors:  P N Levett; S L Branch; C N Edwards
Journal:  Am J Trop Med Hyg       Date:  2000-01       Impact factor: 2.345

3.  Case definitions for infectious conditions under public health surveillance. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1997-05-02

4.  The serological diagnosis of leptospirosis.

Authors:  R T Cursons; P A Pyke; J Penniket
Journal:  N Z Med J       Date:  1982-01-27

5.  Increase of leptospirosis in dengue-negative patients after a hurricane in Puerto Rico in 1996 [correction of 1966].

Authors:  E J Sanders; J G Rigau-Pérez; H L Smits; C C Deseda; V A Vorndam; T Aye; R A Spiegel; R S Weyant; S L Bragg
Journal:  Am J Trop Med Hyg       Date:  1999-09       Impact factor: 2.345

6.  Immunodiagnosis of human leptospirosis by dot-ELISA for the detection of IgM, IgG, and IgA antibodies.

Authors:  M V da Silva; P M Nakamura; E D Camargo; L Batista; A J Vaz; E C Romero; A P Brandao
Journal:  Am J Trop Med Hyg       Date:  1997-06       Impact factor: 2.345

7.  Leptospira fainei sp. nov., isolated from pigs in Australia.

Authors:  P Perolat; R J Chappel; B Adler; G Baranton; D M Bulach; M L Billinghurst; M Letocart; F Merien; M S Serrano
Journal:  Int J Syst Bacteriol       Date:  1998-07

8.  Evaluation of the indirect hemagglutination assay for diagnosis of acute leptospirosis.

Authors:  P N Levett; C U Whittington
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

9.  Leptospirosis in Barbados. A clinical study.

Authors:  C N Edwards; G D Nicholson; T A Hassell; C O Everard; J Callender
Journal:  West Indian Med J       Date:  1990-03       Impact factor: 0.171

10.  Macroscopic agglutination test for rapid diagnosis of human leptospirosis.

Authors:  A P Brandão; E D Camargo; E D da Silva; M V Silva; R V Abrão
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

View more
  39 in total

1.  Evaluation of four commercially available rapid serologic tests for diagnosis of leptospirosis.

Authors:  Mary D Bajani; David A Ashford; Sandra L Bragg; Christopher W Woods; Tin Aye; Richard A Spiegel; Brian D Plikaytis; Bradley A Perkins; Maureen Phelan; Paul N Levett; Robbin S Weyant
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

Review 2.  Leptospira as an emerging pathogen: a review of its biology, pathogenesis and host immune responses.

Authors:  Karen V Evangelista; Jenifer Coburn
Journal:  Future Microbiol       Date:  2010-09       Impact factor: 3.165

3.  Evaluation of a commercial latex agglutination assay for serological diagnosis of leptospirosis.

Authors:  C Hull-Jackson; M B Glass; M D Ari; S L Bragg; S L Branch; C U Whittington; C N Edwards; P N Levett
Journal:  J Clin Microbiol       Date:  2006-05       Impact factor: 5.948

4.  Limited diagnostic capacities of two commercial assays for the detection of Leptospira immunoglobulin M antibodies in Laos.

Authors:  Stuart D Blacksell; Lee Smythe; Rattanaphone Phetsouvanh; Michael Dohnt; Rudy Hartskeerl; Meegan Symonds; Andrew Slack; Manivanh Vongsouvath; Viengmone Davong; Olay Lattana; Simmaly Phongmany; Valy Keolouangkot; Nicholas J White; Nicholas P J Day; Paul N Newton
Journal:  Clin Vaccine Immunol       Date:  2006-10

5.  Leptospira immunoglobulin-like proteins as a serodiagnostic marker for acute leptospirosis.

Authors:  Julio Croda; João G R Ramos; James Matsunaga; Adriano Queiroz; Akira Homma; Lee W Riley; David A Haake; Mitermayer G Reis; Albert I Ko
Journal:  J Clin Microbiol       Date:  2007-03-14       Impact factor: 5.948

6.  Leptospirosis in a subsistence farming community in Brazil.

Authors:  Hênio G Lacerda; Gloria R Monteiro; Carlos C G Oliveira; Fernando B Suassuna; Jose W Queiroz; James D A Barbosa; Daniella R Martins; Mitemayer G Reis; Albert I Ko; Selma M B Jeronimo
Journal:  Trans R Soc Trop Med Hyg       Date:  2008-07-02       Impact factor: 2.184

7.  Asymptomatic renal colonization of humans in the peruvian Amazon by Leptospira.

Authors:  Christian A Ganoza; Michael A Matthias; Mayuko Saito; Manuel Cespedes; Eduardo Gotuzzo; Joseph M Vinetz
Journal:  PLoS Negl Trop Dis       Date:  2010-02-23

8.  Molecular epidemiology of leptospirosis in northern Iran by nested polymerase chain reaction/restriction fragment length polymorphism and sequencing methods.

Authors:  Sedigheh Zakeri; Neda Sepahian; Mandana Afsharpad; Behzad Esfandiari; Peyman Ziapour; Navid D Djadid
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

9.  Challenges of establishing the correct diagnosis of outbreaks of acute febrile illnesses in Africa: the case of a likely Brucella outbreak among nomadic pastoralists, northeast Kenya, March-July 2005.

Authors:  Mary D Ari; Argata Guracha; Moustafa Abdel Fadeel; Charles Njuguna; M Kariuki Njenga; Rosalia Kalani; Hassan Abdi; Osman Warfu; Victor Omballa; Christopher Tetteh; Robert F Breiman; Guillermo Pimentel; Daniel R Feikin
Journal:  Am J Trop Med Hyg       Date:  2011-11       Impact factor: 2.345

Review 10.  Leptospirosis in humans.

Authors:  David A Haake; Paul N Levett
Journal:  Curr Top Microbiol Immunol       Date:  2015       Impact factor: 4.291

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.